Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology. Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology. Startups, Biotech & Health, Battlefield, Battlefield 200, battlefield 20 TAGS: #fyp #foryou #crypto #cryptonews #Trump #ElonMusk #bitcoin #Tech #TechNews TechCrunch Read More
Discover more from GMDegens.io
Subscribe to get the latest posts sent to your email.


